Related Experiment Videos
Force, sarcomere shortening velocity and ATPase activity
Henk E D J ter Keurs1, Nathan Deis, Amir Landesberg
1Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
Advances in Experimental Medicine and Biology
|April 22, 2004
Summary
Cardiac cross-bridge kinetics depend on sarcomere length, influencing muscle mechanics and energetics. ATPase rates of myosin isoforms, not just hydrolysis, likely determine unloaded shortening velocity (V0).
Area of Science:
- Cardiovascular Physiology
- Muscle Mechanics
- Biochemistry
Background:
- Cardiac muscle contraction involves cross-bridge cycling between strong (force-generating) and weak states.
- Myosin isoforms (V1 and V3) in rat cardiac trabeculae exhibit different functional properties.
- Understanding the factors governing cross-bridge kinetics is crucial for cardiac function.
Purpose of the Study:
- To test if the transition rate of cardiac cross-bridges (XB) is a linear function of sarcomere velocity (VSL).
- To determine if myosin ATPase rates explain differences in unloaded shortening velocity (V0) between V1 and V3 isomyosins.
Main Methods:
- Induction of V1 (thyroid hormone) and V3 (PTU) isomyosins in rat trabeculae.
- Measurement of force and sarcomere length using strain gauges and laser diffraction.
- Analysis of force response to controlled shortening at constant VSL during twitch.
Main Results:
- Force decline during shortening showed a linear relationship with VSL, indicating VSL-dependent XB kinetics.
- The rate constant (G1) for force decline did not differ between V1 and V3 isomyosins.
- V0, ATPase rates, and actin-sliding velocities differed 2-2.5 fold between V1 and V3, suggesting isoform-specific differences beyond hydrolysis.
Conclusions:
- VSL-dependent feedback in XB kinetics provides an integrated model for cardiac mechanics and energetics.
- The hydrolytic domain of the cross-bridge is unlikely to solely determine V0.
- Further investigation into the actin-binding domain's role in cardiac sarcomere kinetics is warranted.